Suraksha Diagnostic Promoter Dr. Somnath Chatterjee Further Increases Stake with 7,800 Share Acquisition Aug 18, 2025
Dr. Somnath Chatterjee, Promoter, Chairman, and Joint Managing Director of Suraksha Diagnostic Limited, has acquired 7,800 additional equity shares through the open market. This purchase increased his shareholding from 26,46,968 shares (5.082%) to 26,54,768 shares (5.097%), representing a 0.015% increase in ownership. The company has a paid-up capital of ₹10,41,61,516 with 5,20,80,758 equity shares of ₹2 face value each.
Suraksha Diagnostic Reports Strong Q1 FY26 Performance with 19.5% Revenue Growth Aug 08, 2025
Suraksha Diagnostic Expands Portfolio with Majority Stake Acquisition in Fetomat Wellness Apr 11, 2025
Suraksha Diagnostic Completes Acquisition of 63% Stake in Fetomat Wellness Apr 09, 2025
Suraksha Diagnostic Expands into Fetal Medicine with ₹51.9 Crore Investment in Fetomat Mar 28, 2025
More news about Suraksha Diagnostic
27Mar 25
Suraksha Diagnostic Expands into Fetal Medicine with Strategic Investment in Fetomat
Suraksha Diagnostic Limited has approved a strategic investment of up to ₹5.19 crore in Fetomat Wellness Private Limited, acquiring a 63% stake. The investment will be made through a combination of new equity shares subscription and purchase of existing shares. Fetomat specializes in fetal and maternal medicine, offering services like pregnancy care, prenatal diagnosis, and genetic counseling. This acquisition marks Suraksha's entry into specialized fetal and maternal medicine, expanding its service portfolio. Fetomat has shown significant growth since its incorporation in 2021, with its turnover increasing from ₹0.45 crore in FY 2021-22 to ₹4.11 crore in FY 2023-24.